Nebenwirkungen · Xgeva
XGEVA 120 mg solution for injection XGEVA 120 mg solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 10
HOS-124661 · Präparat HOS-095905
Atypical fractures of the femur In the clinical trial programme overall, atypical femoral fractures have been reported uncommonly in patients treated with XGEVA and the risk increased with longer duration of treatment. Events have occurred during treatment and up to 9 months after treatment was discontinued (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-06-30T11:39:12Z · SHA-256 128fc1cc30bb902fd35b573513956c486b321d921f1c9f82cbb86938b613ea4c · Passage 095cc31bef23d2156c7eefa2148d600ac9d3cb544fef95e7ea4b272b42051de9 · Zeichen 11440–11767 im Abschnitt